MedTrace Logo

The Pharmacokinetic Interaction Between Amlodipine and Losartan

NCT03912285 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2019-04-12

No results posted yet for this study

Summary

This clinical trial aims to assess the pharmacokinetic interaction between amlodipine and losartan in healthy male subjects.

Conditions

  • Healthy

Interventions

DRUG

Amlodipine10mg

Amlodipine 10mg will be administered orally twice a day for 9 days

DRUG

Losartan potassium 100mg

Losartan 100mg will be administered orally once a day for 9 days

DRUG

Amlodipine plus Losartan

Amlodipine plus Losartan same way as "arm: amlodipine" and "arm: losartan"

Sponsors & Collaborators

  • Hanmi Pharmaceutical co., ltd.

    collaborator OTHER

  • Korea University Anam Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-01-10
Primary Completion
2009-03-17
Completion
2009-06-09

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03912285 on ClinicalTrials.gov